Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiation.

Delphine GabillardJean-Baptiste N'TakpéMarie-Laure ChaixGérard M KouameRaoul MohThomas-d'Aquin ToniJérôme Le CarrouSophie KarcherAnani BadjeArlette EmiemeHervé MenanChristine DanelXavier AnglaretSerge P Eholiénull null

Published in: The Journal of antimicrobial chemotherapy (2021)

Starting ART early decreases the risk of virological failure and drug resistance in the medium term. This benefit is of particular importance in countries where access to viral load monitoring and the number of antiretroviral drug lines is limited.

Keyphrases

hiv infected
antiretroviral therapy
human immunodeficiency virus
hiv infected patients
hiv positive
hiv aids
preterm infants
emergency department
hepatitis c virus
south africa
electronic health record